Efficacy and safety of oxcarbazepine in the treatment of children with epilepsy: a meta-analysis of randomized controlled trials.

abstract：Introduction:Sleep disturbance is a major health concern for heroin users receiving methadone maintenance treatment (MMT). The present study was aimed to investigate the predictors for new-onset clinically predominant sleep disturbance (CPSD) among heroin users receiving MMT. Methods:This 2-year retrospective study in...

journal_title：Neuropsychiatric disease and treatment

authors： Li DJ,Chung KS,Wu HC,Hsu CY,Yen CF

更新日期：2018-10-26 00:00:00

abstract：Purpose:This study examined the links between 24-hour activity patterns (specifically, amplitude and timing of wrist activity) and the persisting qualities of clinical antidepressant response to the glutamatergic modulator ketamine. Methods:Twenty-four-hour activity patterns were compared across 5 days of 24-hour acti...

journal_title：Neuropsychiatric disease and treatment

authors： Duncan WC Jr,Slonena EE,Hejazi NS,Brutsche N,Park LT,Henter ID,Ballard ED,Zarate CA Jr

更新日期：2018-10-16 00:00:00

abstract：BACKGROUND:The aim of this paper is to report maternal and neonatal outcomes in pregnant women treated with escitalopram during pregnancy and breastfeeding. METHODS:Women enrolled in the DEGRA Database at the Clinic of Affective Disorders in Pregnancy and Postpartum in Italy, treated during pregnancy with escitalopram...

journal_title：Neuropsychiatric disease and treatment

authors： Bellantuono C,Bozzi F,Orsolini L

更新日期：2013-01-01 00:00:00

abstract：:We report a case in which selegiline, an irreversible monoamine oxidase B (MAO-B) inhibitor, greatly improved depressive symptoms in an adult with stage 5 treatment-resistant major depressive disorder. Four antidepressants and four augmentation therapies had previously been ineffective or intolerable, and electroconvu...

journal_title：Neuropsychiatric disease and treatment

authors： Kitaichi Y,Inoue T,Mitsui N,Nakagawa S,Kameyama R,Hayashishita Y,Shiga T,Kusumi I,Koyama T

更新日期：2013-01-01 00:00:00

abstract：:The aim of this study was to explore the impact of mental illness among patients with migraine. We performed MedLine and PsycINFO searches from 1980 to 2008. Research has systematically documented a strong bidirectional association between migraine and psychiatric disorders. The relationship between migraine and psych...

journal_title：Neuropsychiatric disease and treatment

authors： Pompili M,Serafini G,Di Cosimo D,Dominici G,Innamorati M,Lester D,Forte A,Girardi N,De Filippis S,Tatarelli R,Martelletti P

更新日期：2010-04-07 00:00:00

abstract：Background:Mental disorders affect about one-third of the human population, are typically chronic and significantly decrease the quality of life. Presently, the treatment of mental illnesses is far from adequate with a substantial proportion of the patients being pharmacoresistant and suffering from relapses. One of t...

journal_title：Neuropsychiatric disease and treatment

authors： Latalova K,Sery O,Hosakova K,Hosak L

更新日期：2020-05-06 00:00:00

abstract：Purpose:Individuals with attention deficit/hyperactivity disorder (ADHD) may suffer from emotional dysregulation (ED), although this symptom is not listed among the diagnostic criteria. Methylphenidate (MPH) is useful in reducing emotional symptoms in ADHD. The aim of the present study was to determine both psychosocia...

journal_title：Neuropsychiatric disease and treatment

authors： Suzer Gamli I,Tahiroglu AY

更新日期：2018-05-22 00:00:00

abstract：OBJECTIVE:This study provides insight into the thoughts and opinions of geriatric health-care professionals toward cognitive assessments and the use of emerging technologies, such as eye-tracking, to supplement current tools. METHODS:Two focus group sessions were conducted with nurses and physicians who routinely admi...

journal_title：Neuropsychiatric disease and treatment

authors： Whitehead JC,Gambino SA,Richter JD,Ryan JD

更新日期：2015-06-12 00:00:00

abstract：BACKGROUND:High-dose use of benzodiazepines (BZPs) reportedly causes adverse effects on cognitive function and quality of life in patients with schizophrenia. However, effects of BZPs on the clinical course of schizophrenia have not been clarified. This study was set out to investigate the association between BZPs and ...

journal_title：Neuropsychiatric disease and treatment

authors： Takita Y,Takaesu Y,Ono K,Futenma K,Shimura A,Murakoshi A,Komada Y,Inoue Y,Inoue T

更新日期：2016-12-15 00:00:00

abstract：Purpose:Color preferences vary among normal individuals and psychiatric patients, and this might be related to their different levels of hypnotic susceptibility. We hypothesized that individuals with higher hypnotic susceptibility prefer more arousing colors such as red. Patients and methods:Out of 440 participants, w...

journal_title：Neuropsychiatric disease and treatment

authors： Yu E,Zhu J,Tan Y,Liao Z,Qiu Y,Zhang B,Wang C,Wang W

更新日期：2018-01-30 00:00:00

abstract：BACKGROUND:Recently, the sigma-1 receptor has been shown to play a significant role in the neural transmission of mood by regulating N-methyl-D-aspartate receptors. Additionally, the sigma-1 receptor has been reported to influence cognitive functions including learning and memory. In this study, we measured plasma sigm...

journal_title：Neuropsychiatric disease and treatment

authors： Shimizu H,Takebayashi M,Tani M,Tanaka H,Yamagata B,Kurosawa K,Yamada H,Hachisu M,Hisaoka-Nakashima K,Okada-Tsuchioka M,Mimura M,Iwanami A

更新日期：2013-01-01 00:00:00

abstract：:Objective: To explore the efficacy and safety of "cocktail therapy" in Parkinson's disease with dementia (PDD). Patients and methods: Sixty patients with PDD were randomly assigned to the test group (n=30) and a control group (n=30). The control group received 10 mg of donepezil hydrochloride tablets orally, once a da...

journal_title：Neuropsychiatric disease and treatment

authors： Zhang C,Zang Y,Song Q,Li H,Hu L,Zhao W,Feng S,Gu F,Zhao F,Zhang C

更新日期：2019-06-24 00:00:00

abstract：:Olanzapine long-acting injection (OLAI) is a crystalline salt composed of olanzapine and pamoic acid, which permits a depot intramuscular formulation of olanzapine. The half-life of olanzapine pamoate is 30 days, and its steady state is reached approximately at 12 weeks. Oral supplementation of olanzapine is not requi...

journal_title：Neuropsychiatric disease and treatment

authors： Di Lorenzo R,Brogli A

更新日期：2010-09-07 00:00:00

abstract：BACKGROUND:The main aim of this study was to assess the reliability and structural validity of the French version of the 12-item version of the Personal Report of Confidence as Speaker (PRCS), one of the most promising measurements of public speaking fear. METHODS:A total of 611 French-speaking volunteers were adminis...

journal_title：Neuropsychiatric disease and treatment

authors： Heeren A,Ceschi G,Valentiner DP,Dethier V,Philippot P

更新日期：2013-01-01 00:00:00

abstract：Background:Levodopa-induced dyskinesia (LID) is a troublesome problem in the treatment of Parkinson's disease (PD). The mechanisms of LID are still mysterious. Recently, the interaction between Shp-2 and D1 dopamine receptor (D1R) has been identified to be indispensable in the D1R-mediated extracellular signal-regulate...

journal_title：Neuropsychiatric disease and treatment

authors： Wu N,Wan Y,Song L,Qi C,Liu Z,Gan J

更新日期：2018-07-05 00:00:00

abstract：BACKGROUND:Antipsychotics have been used for more than 50 years in the treatment of schizophrenia and many other psychiatric disorders. Prolactin levels usually increase in patients treated with risperidone. Aripiprazole, which has a unique effect as an antipsychotic, is a D2 receptor partial agonist. It is an atypical...

journal_title：Neuropsychiatric disease and treatment

authors： Ranjbar F,Sadeghi-Bazargani H,Niari Khams P,Arfaie A,Salari A,Farahbakhsh M

更新日期：2015-03-02 00:00:00

abstract：Purpose:Cardiovascular and metabolic adverse events are costly to treat, and their incidence is increased amongst people with schizophrenia, with different rates observed for second-generation antipsychotics. To inform treatment choice, this study sought to estimate the lifetime costs associated with antipsychotic choi...

journal_title：Neuropsychiatric disease and treatment

authors： Kearns B,Cooper K,Cantrell A,Thomas C

更新日期：2021-01-20 00:00:00

abstract：Background:Displaced people experience different traumatic events. This can have serious and long-lasting consequences in terms of physical and mental health outcome. Post-traumatic stress disorder (PTSD) is the most frequent mental disorder following traumatic exposure. In 2018 Ethiopia saw the highest number of inter...

journal_title：Neuropsychiatric disease and treatment

authors： Madoro D,Kerebih H,Habtamu Y,G\/Tsadik M,Mokona H,Molla A,Wondie T,Yohannes K

更新日期：2020-10-07 00:00:00

abstract：:Tuberous sclerosis complex (TSC) is a relatively rare genetic disorder, affecting one in 6,000 births. Mammalian target of rapamycin (mTOR) inhibitors, such as everolimus, which have been previously used to prevent solid organ transplant rejection, augment anticancer treatment regimens, and prevent neovascularization ...

journal_title：Neuropsychiatric disease and treatment

authors： Capal JK,Franz DN

更新日期：2016-08-25 00:00:00

abstract：BACKGROUND:Burden on caregivers of children/adolescents with attention-deficit/hyperactivity disorder (ADHD) is multidimensional, but incompletely understood. OBJECTIVE:To analyze caregiver burden across the concepts of work, social/family life, and parental worry/stress, in relation to selected contributing factors. ...

journal_title：Neuropsychiatric disease and treatment

authors： Fridman M,Banaschewski T,Sikirica V,Quintero J,Erder MH,Chen KS

更新日期：2017-02-07 00:00:00

abstract：PURPOSE:Major depressive disorder (MDD) is highly prevalent in patients with a chronic physical condition, and this comorbidity has a negative influence on quality of life, health care costs, self-care, morbidity, and mortality. Research has shown that collaborative care (CC) may be a cost-effective treatment. However,...

journal_title：Neuropsychiatric disease and treatment

authors： Goorden M,van der Feltz-Cornelis CM,van Steenbergen-Weijenburg KM,Horn EK,Beekman AT,Hakkaart-van Roijen L

更新日期：2017-07-18 00:00:00

abstract：:The history and present status of the definition, prevalence, neurobiology, and treatment of atypical depression (AD) is presented. The concept of AD has evolved through the years, and currently, in Diagnostic and Statistical Manual of Mental Disorders (DSM), Fifth Edition, the specifier of depressive episode with aty...

journal_title：Neuropsychiatric disease and treatment

authors： Łojko D,Rybakowski JK

更新日期：2017-09-20 00:00:00

abstract：Background:Based on inconsistent sensory alterations demonstrated in cluster headache (CH), the aim of this study was to determine whether patients with CH develop sensory changes in the symptomatic side compared to the asymptomatic side. Methods:Quantitative sensory testing (QST), including pressure pain threshold (P...

journal_title：Neuropsychiatric disease and treatment

authors： Malo-Urriés M,Hidalgo-García C,Estébanez-de-Miguel E,Tricás-Moreno JM,Santos-Lasaosa S,Jahanshahi M

更新日期：2018-12-10 00:00:00

abstract：BACKGROUND:We aimed to investigate the current prevalence of sexual dysfunction (SD), mood, anxiety, and personality disorders in female patients with fibromyalgia (FM). METHODS:This case-control study involved 96 patients with FM and 94 healthy women. The SD diagnosis was based on a psychiatric interview in accordanc...

journal_title：Neuropsychiatric disease and treatment

authors： Kayhan F,Küçük A,Satan Y,İlgün E,Arslan Ş,İlik F

更新日期：2016-02-16 00:00:00

abstract：Objective:To investigate the relationship between Hamilton Depression Rating Scale (HAM-D) score and psychiatrists' judgment of working ability in patients with major depressive disorder (MDD) and painful physical symptoms. Methods:This was a prospective, observational, 12-week study in patients who received duloxetin...

journal_title：Neuropsychiatric disease and treatment

authors： Kuga A,Otsubo T,Tsuji T,Hayashi S,Imagawa H,Fujikoshi S,Escobar R

更新日期：2019-04-05 00:00:00

abstract：:Adjunctive use of methylphenidate, a central stimulant, has been considered as a potential therapeutic choice for patients with refractory unipolar, geriatric, or bipolar depression, and depression secondary to medical illness. We present a case of bipolar depression in which the patient responded significantly to aug...

journal_title：Neuropsychiatric disease and treatment

authors： Adida M,Azorin JM

更新日期：2014-04-02 00:00:00

abstract：:[This retracts the article DOI: 10.2147/NDT.S229513.]. ...

journal_title：Neuropsychiatric disease and treatment

authors：

更新日期：2020-04-16 00:00:00

abstract：:Treatment guidelines from the American Academy of Child and Adolescent Psychiatry and the American Academy of Pediatrics state that stimulant medications have the most evidence for safety and efficacy in the treatment of childhood attention deficit hyperactivity disorder (ADHD). Longer-acting stimulants are thus consi...

journal_title：Neuropsychiatric disease and treatment

authors： Domnitei D,Madaan V

更新日期：2010-05-25 00:00:00

abstract：BACKGROUND:Anterior cingulate cortex (ACC) dysfunction is implicated in schizophrenia by numerous strands of scientific investigation. Functional neuroimaging studies of the ACC in schizophrenia have shown task-related hypo-activation, hyper-activation, and normal activation relative to comparison subjects. Interpretin...

journal_title：Neuropsychiatric disease and treatment

authors： Adams R,David AS

更新日期：2007-02-01 00:00:00

abstract：:Panic disorder (PD) is a disabling condition which appears in late adolescence or early adulthood and affects more frequently women than men. PD is frequently characterized by recurrences and sometimes by a chronic course and, therefore, most patients require long-term treatments to achieve remission, to prevent relap...

journal_title：Neuropsychiatric disease and treatment

authors： Marchesi C

更新日期：2008-02-01 00:00:00